Skip to main content

Table 3 Disease-specific disability weightings, IHME Global Burden of Disease Study 2016 [33] unless otherwise stated

From: Bridging the gap: an economic case study of the impact and cost effectiveness of comprehensive healthcare intermediaries in rural Mexico

Condition

Disability weight

Skin cancer

 Diagnosis and primary therapy phase of skin melanoma or other neoplasmsa

0.29 (0.19–0.40)

 Moderate disfigurement due to squamous cell carcinoma

0.07 (0.04–0.10)

 Disfigurement due to basal cell carcinoma

0.01 (0.01–0.02)

Hernia

 Severe

0.32 (0.22–0.44)

 Moderate

0.11 (0.08–0.16)

Cataract

 Severe vision loss

0.18 (0.13–0.26)

 Moderate vision loss

0.03 (0.02–0.05)

Heart conditions

 Severe congenital heart disease and heart failure

0.21 (0.15–0.29)

 Moderate congenital heart disease and moderate heart failure

0.07 (0.05–0.10)

 Mild congenital heart disease and mild heart failure

0.04 (0.03–0.06)

Epilepsy

 Severe epilepsy, > 1 seizure per month

0.55 (0.38–0.71)

 Less severe epilepsy, 1–11 seizures per year

0.26 (0.17–0.37)

Gall bladder conditions

 Cholecystitis: severe symptomatic gallbladder disease

0.32 (0.22–0.44)

 Cholelithiasis: moderate symptomatic gallbladder disease

0.11 (0.08–0.16)

Hypothyroidism or hyperthyroidism

 Moderate endocrine, metabolic, blood and immune disorders

0.15 (0.10–0.20)

Kidney stones/nephritis

0.11 (0.08–0.16)

Breast cancer

 Primary diagnosis and therapy phase

0.29 (0.19–0.40)

 Post-mastectomy

0.08 (0.05–0.12)

Cryptorchidism

 Classified as other congenital birth defect

0.22 (0.08–0.22)

  1. aSimilar to diagnosis disability weight of 0.26 applied for skin cancer by Soerjomataram et al. [34]
  2. bSame disability weight as used in Poenaru et al. [9]